Elanco Animal Health Financial Statements
NYSE: ELANHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Elanco Animal Health revenue and earnings
In fiscal 2025, Elanco Animal Health generated $4.71 billion in revenue, up 6.2% from fiscal 2024, its 3rd consecutive year of revenue growth. Elanco Animal Health reported a net loss of $232.0 million, compared with net income of $338.0 million a year earlier. Gross margin was 55.0% (up from 54.9%).
Diluted earnings per share came in at -$0.47, down from $0.68. Over the last 5 fiscal years, ELAN's revenue has grown at a 7.6% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Elanco Animal Health income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.71B | 4.44B | 4.42B | 4.41B | 4.76B | 3.27B | 3.07B | 3.07B | 2.89B | 2.91B |
| Revenue growth (YoY) | +6.22% | +0.50% | +0.14% | -7.41% | +45.55% | +6.58% | +0.14% | +6.15% | -0.84% | — |
| Cost of Revenue | 2.12B | 2.00B | 1.93B | 1.91B | 2.13B | 1.67B | 1.47B | 1.57B | 1.49B | 1.41B |
| Gross Profit | 2.59B | 2.44B | 2.49B | 2.50B | 2.63B | 1.61B | 1.60B | 1.49B | 1.40B | 1.50B |
| Research & Development | 368.00M | 344.00M | 327.00M | 321.00M | 369.00M | 329.00M | 270.00M | 246.60M | 251.70M | 265.80M |
| Selling, General & Admin | 1.43B | 1.31B | 1.28B | 1.26B | 1.40B | 997.00M | 760.00M | 735.20M | 779.80M | 784.80M |
| Interest Expense | 220.00M | 235.00M | 277.00M | 241.00M | 236.00M | 150.00M | 79.00M | 29.60M | 0 | 0 |
| Other Income (Expense) | — | — | -75.00M | -32.00M | -5.00M | 178.00M | -28.00M | -41.30M | 100.00K | 2.80M |
| Pretax Income | -224.00M | 488.00M | -1.20B | -72.00M | -571.00M | -677.00M | 78.00M | 114.10M | -232.60M | -22.40M |
| Income Tax | 8.00M | 150.00M | 36.00M | 6.00M | -88.00M | -103.00M | 10.00M | 27.60M | 78.10M | 25.50M |
| Net Income | -232.00M | 338.00M | -1.23B | -78.00M | -483.00M | -574.00M | 68.00M | 86.50M | -310.70M | -47.90M |
| Net Income growth (YoY) | -168.64% | — | — | — | — | -944.12% | -21.39% | — | — | — |
| EPS (Basic) | -0.47 | 0.68 | -2.50 | -0.16 | -0.99 | -1.30 | 0.18 | 0.28 | -1.06 | -0.16 |
| EPS (Diluted) | -0.47 | 0.68 | -2.50 | -0.16 | -0.99 | -1.30 | 0.18 | 0.28 | -1.06 | -0.16 |
| Shares Outstanding (Basic) | 496.40M | 494.00M | 492.30M | 488.30M | 487.20M | 441.40M | 369.00M | 313.70M | 293.30M | 293.29M |
| Shares Outstanding (Diluted) | 496.40M | 497.30M | 492.30M | 488.30M | 487.20M | 441.40M | 370.30M | 313.70M | 293.30M | 293.30M |
| Gross Margin | 54.99% | 54.88% | 56.28% | 56.63% | 55.25% | 49.07% | 52.13% | 48.68% | 48.29% | 51.64% |
| Net Margin | -4.92% | 7.61% | -27.87% | -1.77% | -10.14% | -17.54% | 2.21% | 2.82% | -10.75% | -1.64% |
This table shows 10 annual periods of Elanco Animal Health's income statement, from FY 2025 back to FY 2016, across 16 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow ELAN's reporting calendar. What is a income statement?